Latest / Dementia Researcher Blogs
Dr Emma Law - pTau217 Blood Test for Alzheimer's: What the FDA Clearance Means
Dr Emma Law narrates her blog written for Dementia Researcher.
The FDA has cleared Roche's Elecsys pTau217 blood test to help identify amyloid pathology in people aged 55 and over who are already showing signs of cognitive decline. Most of the attention has gone to what that means for diagnosis and for access to new treatments. In this blog, Emma takes a different angle, asking what it changes for the people who design and deliver dementia studies. Her view is that a clearance like this reshapes the economics of recruitment, opens up questions about the earliest stages of disease that were…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.